ALK GBSC
About Us
News
Careers
Contact
Zgłaszanie działań niepożądanych
Fulltext search
Search
ALK’s pivotal phase 3 trial in children published in reputable scientific journal
Link
https://www.globenewswire.com/news-release/2024/11/27/2988155/0/en/ALK-s-pivota…
Created date
Wed, 11/27/2024 - 12:00
Nasdaq ID
2988155
Last updated:
2024.11.27